IOBCF Quote, Financials, Valuation and Earnings

Galapagos NV has a net margin of -- compared to Ion Beam Applications SA's net margin of -84.26%. Ion Beam Applications SA's return on equity of 8.22% beat Galapagos NV's return on equity of 7.25%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Galapagos NV has an analysts' consensus of $31.41 which suggests that it could grow by 10.65%. Given that Galapagos NV has higher upside potential than Ion Beam Applications SA, analysts believe Galapagos NV is more attractive than Ion Beam Applications SA.

Ion Beam Applications SA has a beta of 0.902, which suggesting that the stock is 9.845% less volatile than S&P 500. In comparison Galapagos NV has a beta of 0.214, suggesting its less volatile than the S&P 500 by 78.61%.

Ion Beam Applications SA has a quarterly dividend of $0.18 per share corresponding to a yield of 1.32%. Galapagos NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays -67.19% of its earnings as a dividend. Galapagos NV pays out -- of its earnings as a dividend.

Ion Beam Applications SA quarterly revenues are --, which are smaller than Galapagos NV quarterly revenues of $65.8M. Ion Beam Applications SA's net income of -- is lower than Galapagos NV's net income of -$55.5M. Notably, Ion Beam Applications SA's price-to-earnings ratio is 46.57x while Galapagos NV's PE ratio is 8.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.82x versus 6.62x for Galapagos NV. Usually stocks with elevated PS ratios are considered overvalued.

MDxHealth SA has a net margin of -- compared to Ion Beam Applications SA's net margin of -47.99%. Ion Beam Applications SA's return on equity of 8.22% beat MDxHealth SA's return on equity of -650.14%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand MDxHealth SA has an analysts' consensus of $7.1750 which suggests that it could grow by 157.02%. Given that MDxHealth SA has higher upside potential than Ion Beam Applications SA, analysts believe MDxHealth SA is more attractive than Ion Beam Applications SA.

Ion Beam Applications SA has a beta of 0.902, which suggesting that the stock is 9.845% less volatile than S&P 500. In comparison MDxHealth SA has a beta of -384,676.085, suggesting its less volatile than the S&P 500 by 38467708.461%.

Ion Beam Applications SA has a quarterly dividend of $0.18 per share corresponding to a yield of 1.32%. MDxHealth SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays -67.19% of its earnings as a dividend. MDxHealth SA pays out -- of its earnings as a dividend.

Ion Beam Applications SA quarterly revenues are --, which are smaller than MDxHealth SA quarterly revenues of $23.3M. Ion Beam Applications SA's net income of -- is lower than MDxHealth SA's net income of -$11.2M. Notably, Ion Beam Applications SA's price-to-earnings ratio is 46.57x while MDxHealth SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.82x versus 0.90x for MDxHealth SA. Usually stocks with elevated PS ratios are considered overvalued.

Nyxoah SA has a net margin of -- compared to Ion Beam Applications SA's net margin of -1347.39%. Ion Beam Applications SA's return on equity of 8.22% beat Nyxoah SA's return on equity of -51.1%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Nyxoah SA has an analysts' consensus of -- which suggests that it could grow by 58.99%. Given that Nyxoah SA has higher upside potential than Ion Beam Applications SA, analysts believe Nyxoah SA is more attractive than Ion Beam Applications SA.

Ion Beam Applications SA has a beta of 0.902, which suggesting that the stock is 9.845% less volatile than S&P 500. In comparison Nyxoah SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Ion Beam Applications SA has a quarterly dividend of $0.18 per share corresponding to a yield of 1.32%. Nyxoah SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays -67.19% of its earnings as a dividend. Nyxoah SA pays out -- of its earnings as a dividend.

Ion Beam Applications SA quarterly revenues are --, which are smaller than Nyxoah SA quarterly revenues of $1.4M. Ion Beam Applications SA's net income of -- is lower than Nyxoah SA's net income of -$18.8M. Notably, Ion Beam Applications SA's price-to-earnings ratio is 46.57x while Nyxoah SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.82x versus 54.79x for Nyxoah SA. Usually stocks with elevated PS ratios are considered overvalued.

UCB SA has a net margin of -- compared to Ion Beam Applications SA's net margin of --. Ion Beam Applications SA's return on equity of 8.22% beat UCB SA's return on equity of 2.64%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand UCB SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Ion Beam Applications SA has higher upside potential than UCB SA, analysts believe Ion Beam Applications SA is more attractive than UCB SA.

Ion Beam Applications SA has a beta of 0.902, which suggesting that the stock is 9.845% less volatile than S&P 500. In comparison UCB SA has a beta of 0.734, suggesting its less volatile than the S&P 500 by 26.64%.

Ion Beam Applications SA has a quarterly dividend of $0.18 per share corresponding to a yield of 1.32%. UCB SA offers a yield of 0.74% to investors and pays a quarterly dividend of $0.72 per share. Ion Beam Applications SA pays -67.19% of its earnings as a dividend. UCB SA pays out 73.47% of its earnings as a dividend. UCB SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than UCB SA quarterly revenues of --. Ion Beam Applications SA's net income of -- is lower than UCB SA's net income of --. Notably, Ion Beam Applications SA's price-to-earnings ratio is 46.57x while UCB SA's PE ratio is 150.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.82x versus 6.55x for UCB SA. Usually stocks with elevated PS ratios are considered overvalued.